1. Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients
   Zhisen Shen et al, 2016, Clinical Biochemistry CrossRef
2. Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status
   Qiong Wu et al, 2023, International Journal of Molecular Sciences CrossRef
3. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
   Wei Wu et al, 2021, Pharmacological Research CrossRef
4. Elucidating the clonal relationship of esophageal second primary tumors in patients with laryngeal squamous cell carcinoma
   Meixuan Wan et al, 2023, Infectious Agents and Cancer CrossRef
5. Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis
   Fucheng Cai et al, 2016, PLOS ONE CrossRef
6. A Low-Rank Representation Method Regularized by Dual-Hypergraph Laplacian for Selecting Differentially Expressed Genes
   Xiu-Xiu Xu et al, 2019, Human Heredity CrossRef
7. Association of RUNX3 Methylation with Clinical Outcome and Cell Migration/Invasion in Laryngeal Squamous Cell Carcinoma
   Zhao-hui Liu et al, 2016, Cancer Investigation CrossRef
8. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma
   Zhisen Shen et al, 2016, Gene CrossRef
9. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis
   Tianyi Wu et al, 2016, Oncotarget CrossRef
10. Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O6-methylguanine DNA methyltransferase (MGMT)
    Yasamin Yousefi et al, 2024, Journal of Neuro-Oncology CrossRef
11. TGFB2 and BCL2L11 methylation in male laryngeal cancer patients
    Zhisen Shen et al, 2016, Oncology Letters CrossRef
12. Circ_0000218 plays a carcinogenic role in laryngeal cancer through regulating microRNA-139-3p/Smad3 axis
    Yiyang Bai et al, 2020, Pathology - Research and Practice CrossRef